What Are Tumor Markers (Tumor Index)? Does a High Level Mean Cancer? Common Markers and Correct Interpretation
Tumor markers (tumor index) are measurable substances in the blood that may be produced by cancer cells, by the body in response to cancer, or by benign (non-cancerous) conditions. A high level does not equal cancer—inflammation, smoking, pregnancy, liver/kidney issues, etc., can also raise levels; a normal level does not completely rule out cancer. According to the U.S. National Cancer Institute (NCI), most tumor markers are not recommended as standalone screening tools for asymptomatic individuals; they are primarily used for treatment monitoring and follow-up in diagnosed patients. Below is a summary of common markers, their significance, and correct interpretation. This is neutral information, not medical diagnosis or advice; please discuss results with your doctor.
What are tumor markers? Can they be used to screen for cancer?
Tumor markers are measurable substances in the blood that may be produced by cancer cells, by the body in response to cancer, or by benign conditions. According to the NCI, most circulating tumor markers are 'ineffective' for screening asymptomatic individuals (insufficient sensitivity and specificity) and are not recommended as standalone general screening:
- Primary legitimate use: monitoring treatment response and recurrence in diagnosed cancer patients
- A few well-defined high-risk groups have a monitoring role (e.g., liver cirrhosis patients using AFP plus abdominal ultrasound for liver cancer surveillance)
- Diagnosis still requires clinical, imaging, and pathological (biopsy) confirmation; a single value cannot diagnose
Does a high level mean cancer?
No. According to the NCI, a high tumor marker level does not mean cancer—many benign conditions can raise levels; conversely, a normal level does not rule out cancer (false negatives). Looking at a single number can easily lead to misjudgment:
- Elevation may be due to benign causes such as inflammation, infection, smoking, pregnancy, liver/kidney dysfunction
- A normal level does not guarantee absence of cancer (some cancers do not raise corresponding markers)
- An isolated abnormal value requires physician interpretation in clinical context, often needing repeat testing and imaging
Common tumor markers and their associations (for understanding only, not diagnosis)
Below are 'associations' of common markers and common benign interfering factors (used for monitoring, not diagnosis):
- CEA (carcinoembryonic antigen): associated with colorectal cancer, mainly monitors known cancer; smoking, inflammatory bowel disease, etc., can also raise levels
- AFP (alpha-fetoprotein): associated with liver cancer and germ cell tumors; high-risk groups often use with ultrasound for surveillance; pregnancy, hepatitis also raise levels
- PSA (prostate-specific antigen): associated with the prostate; screening is a personalized, shared decision with controversy; benign prostatic hyperplasia, prostatitis also raise levels
- CA-125: used for ovarian cancer monitoring, not recommended for general screening; menstruation, endometriosis, pregnancy, uterine fibroids also raise levels
- CA 19-9: associated with pancreatic and biliary tract cancer (mainly monitoring); benign biliary disease raises levels, and about 5–10% of people are non-secretors, so levels may be low even with cancer
- CA 15-3: used for breast cancer monitoring, not for screening
Is it worth adding multiple tumor markers to a paid health check package?
Evidence shows that performing multiple tumor marker panels on asymptomatic healthy individuals has not been proven to reduce mortality, and due to low prevalence, false-positive rates are high, often causing anxiety and unnecessary follow-up tests (e.g., PET, endoscopy). No professional medical organization recommends tumor marker panels for general screening:
- False positives lead to anxiety and additional invasive follow-up and costs
- Truly evidence-based screenings that reduce mortality are the government's five-cancer screenings (see below), not tumor marker blood tests
- Whether to add should be based on individual risk and discussion with a doctor, not on the idea that more panels mean more reassurance
What should I do if my report shows elevated tumor markers?
First, do not panic. An elevated value does not equal cancer; it needs to be interpreted by a physician in the context of your medical history, symptoms, and other tests:
- Discuss with your doctor; repeat testing or imaging (ultrasound, CT, endoscopy, etc.) may be arranged for further clarification
- Provide complete medical history (medications, smoking, chronic diseases, pregnancy, etc., which may affect values)
- Follow your doctor's recommendations for follow-up; this page is neutral information, not personal medical diagnosis or advice
FAQ
If my health check report shows high tumor markers, does it mean I have cancer?
Not necessarily. According to the NCI, a high tumor marker level does not mean cancer—benign causes such as inflammation, infection, smoking, pregnancy, liver/kidney issues can also raise levels; a normal level does not completely rule out cancer. An isolated abnormal value requires interpretation by a physician in the context of medical history and other tests, often needing repeat testing or imaging. Please discuss with your doctor; do not panic or self-diagnose.
Can tumor markers be used to screen for cancer?
Most tumor markers are not recommended as standalone screening tools for asymptomatic individuals due to insufficient sensitivity and specificity and high false-positive rates. They are primarily used for treatment monitoring and recurrence tracking in diagnosed patients. A few high-risk groups have a monitoring role (e.g., liver cirrhosis patients using AFP plus ultrasound for liver cancer surveillance). Diagnosis still requires imaging and pathology.
What are CEA, AFP, PSA, CA-125?
These are common tumor markers: CEA is associated with colorectal cancer, AFP with liver cancer, PSA with the prostate, and CA-125 used for ovarian cancer monitoring. They are 'association' markers used for monitoring, not diagnosis, and can be elevated due to benign conditions (e.g., smoking, hepatitis, benign prostatic hyperplasia, menstruation). Values must be interpreted by a physician in clinical context.
Should I get PSA tested?
PSA (prostate-specific antigen) screening is a personalized, shared decision-making process with controversy internationally (e.g., the U.S. USPSTF recommends discussion with a doctor for men aged 55–69 before deciding). Benign prostatic hyperplasia and prostatitis can also raise PSA. Discuss personal risk and pros/cons with your doctor before deciding, rather than universal testing.
Is it worth adding multiple tumor markers to a paid health check package?
Evidence shows that performing multiple tumor marker panels on asymptomatic healthy individuals has not been proven to reduce mortality, and false-positive rates are high, leading to anxiety and unnecessary follow-up tests. The truly evidence-based screenings are the government's five-cancer screenings (see below), not tumor marker blood tests. Whether to add tumor markers should be based on individual risk and discussion with a doctor, not on the idea that more tests mean more reassurance.
What are the truly effective cancer screenings?
The National Health Administration provides five evidence-based cancer screenings that reduce mortality: Pap smear, mammography, fecal occult blood test (colorectal cancer), oral mucosal examination, and low-dose computed tomography (LDCT) for lung cancer (for heavy smokers or high-risk individuals). These differ from tumor marker blood tests. It is recommended to utilize these resources first. See our page 'Government-Subsidized Cancer Screenings' for details.
This page is a neutral compilation of information for reference only, not Medical advice, and does not constitute any diagnostic commitment.